WCN26-6076 Dapagliflozin Protects against Cisplatin-Induced Acute Kidney Injury Through Direct Actions on Primary Human Renal Proximal Tubular Epithelial Cells

Read full text Summarise with VIRAT
Authors: Iori Morita, Yuta Sekiguchi, Makiko Mori, Yuki Nakao, Shintaro Mandai, Hiroaki Kikuchi, Fumiaki Ando, Koichiro Susa, Takayasu Mori, Eisei Sohara, Shinichi Uchida, Yutaro Mori
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Sodium-glucose cotransporter 2 (SGLT2) inhibitors have demonstrated significant protective effects in patients with chronic kidney disease (CKD), extending beyond glucose-lowering properties. Emerging evidence also indicates benefits in acute kidney injury (AKI). However, the mechanisms underlying these protective actions–particularly at the tubular epithelial level–remain poorly defined. We hypothesized that SGLT2 inhibitors exert direct cytoprotective effects on renal tubular epithelial cells independent of systemic hemodynamic influences.

Fields of Study & Subjects

Acute Kidney Injury Research Chemotherapy-induced organ toxicity mitigation Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
103992–103992
Publication date
25 March 2026
Language
EN